US Pharma Deals Midyear Outlook 2026: Why Dea...

Glenn Hunzinger, PwC's US Health Industries Leader, speaks with James Woods, PwC's US MedTech Leader, about the forces shaping MedTech dealmaking in 2026. Despite capital market pressures, supply chain challenges, and geopolitical uncertainty, companies continue to invest in inno ...  عرض المزيد

Glenn Hunzinger, PwC's US Health Industries Leader, speaks with Dan Farrell, PwC's Health Services Deals Leader, about the forces shaping health services dealmaking in 2026. Despite ongoing reimbursement uncertainty, rising medical costs, and operational pressures, investors cont ...  عرض المزيد

PwC U.S. Health Services Advisory Leader Thom Bales goes into top healthcare challenges, advancements in care delivery, digital health lowering costs, and how health systems should consider addressing diverse patients via digital health.

Read more > Listen to the podcast (duration: 28:51) > In a value-based economic model, payers' strength will be to bring analytic capability, operational capability, technology, and customer relationships to the table. But the care will be delivered and managed at the physician l ...  عرض المزيد

Welcome to the Strategy& Insider Podcast. In our first season, we will discuss some of the most fundamental questions about the Future of Health. Our guests are experts across all sectors of the healthcare industry including pharma executives, leading academics and medical physic ...  عرض المزيد

Read more > Listen to the podcast (duration: 19:51) > How AMCs are changing to tackle the broader healthcare continuum including social determinants of health and shifting health to the home.See www.mckinsey.com/privacy-policy for privacy information